Profile picture

Doctor Pruthvi C Revaiah

New York (United States of America)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Impact of evolocumab on coronary plaque stratified by very high-risk ASCVD status: a YELLOW III sub study
Presentation
Impact of evolocumab on coronary plaque stratified by very high-risk ASCVD status: a YELLOW III sub study
See more
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study
Presentation
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study
See more
Serial ai based comprehensive coronary physiological assessment before and after intensive lipid lowering therapy: YELLOW III substudy
Presentation
Serial ai based comprehensive coronary physiological assessment before and after intensive lipid lowering therapy: YELLOW III substudy
See more
Residual risk according to lesion complexity phenotypes after intravascular imaging-guided percutaneous coronary intervention
Presentation
Residual risk according to lesion complexity phenotypes after intravascular imaging-guided percutaneous coronary intervention
See more
Intra-coronary imaging before and after PCSK9 inhibition stratified by residual inflammatory risk: a serial imaging sub-study of YELLOW III
Presentation
Intra-coronary imaging before and after PCSK9 inhibition stratified by residual inflammatory risk: a serial imaging sub-study of YELLOW III
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources